18 results
8-K
EX-1.1
d2hayy
8 Dec 20
Arcturus Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock
9:01am
8-K
EX-1.1
1ch6rg q1
29 Jul 20
Arcturus Therapeutics Announces Pricing of $173.0 Million Public Offering of Common Stock
6:02am
8-K
EX-1.1
2vhkv
17 Apr 20
Entry into a Material Definitive Agreement
6:06am
8-K
EX-10.1
ws7lk1
27 Mar 20
Entry into a Material Definitive Agreement
5:20pm
10-K
7ido 8wuvg6
16 Mar 20
Annual report
11:09am
8-K
EX-10.1
2tr9lq238 uma
27 Sep 19
Arcturus Therapeutics Announces $9.8 Million Registered Direct Offering of Common Stock
4:25pm
8-K
EX-10.1
ivcjui9ya 67mlllkb
5 Aug 19
Arcturus Therapeutics Announces $2.3 Million Additional Registered Direct Offering of Common Stock
9:14am
8-K
EX-10.1
0knhpo4zt
2 Aug 19
Arcturus Therapeutics Announces $10.9 Million Registered Direct Offering of Common Stock
4:29pm
8-K
EX-10.1
lsm vkelaagxv1a2
20 Jun 19
License Agreement to Develop Additional Nucleic Acid Therapies for Rare Diseases
6:06am
424B3
tjo0snzo
12 Apr 19
Prospectus supplement
4:39pm
S-4/A
vj3766z2k4qi42
11 Apr 19
Registration of securities issued in business combination transactions (amended)
5:26pm
S-4
n4j2qyfs nhbyhs3e8j
15 Mar 19
Registration of securities issued in business combination transactions
9:35pm
- Prev
- 1
- Next